Lenalidomide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
82293-034 -
Package NDC
82293-034-10 -
Application number
ANDA217281 -
SPL ID
5e7ce385-737e-736a-e063-6294a90aa87a -
SPL set ID
2166bbdf-eb12-4564-b9e4-b63ca21312bc -
UNII
F0P408N6V4 -
RxCUI
602910 -
RxCUI
602912 -
RxCUI
643712 -
RxCUI
643720 -
RxCUI
1242231 -
RxCUI
1428947
What the source publishes
- Labeler
- Novugen Pharma (USA) LLC
- Active ingredients
- Lenalidomide
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lenalidomide",
"splId": "5e7ce385-737e-736a-e063-6294a90aa87a",
"labels": [
{
"setId": "2166bbdf-eb12-4564-b9e4-b63ca21312bc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2166bbdf-eb12-4564-b9e4-b63ca21312bc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2166bbdf-eb12-4564-b9e4-b63ca21312bc"
}
],
"routes": [
"ORAL"
],
"labeler": "Novugen Pharma (USA) LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "28 CAPSULE in 1 BOTTLE (82293-034-10)",
"package_ndc": "82293-034-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20260410"
}
],
"productId": "82293-034_5e7ce385-737e-736a-e063-6294a90aa87a",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "82293-034",
"deaSchedule": null,
"genericName": "Lenalidomide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LENALIDOMIDE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA217281",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260410",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000184014"
],
"unii": [
"F0P408N6V4"
],
"rxcui": [
"602910",
"602912",
"643712",
"643720",
"1242231",
"1428947"
],
"spl_set_id": [
"2166bbdf-eb12-4564-b9e4-b63ca21312bc"
],
"pharm_class_epc": [
"Thalidomide Analog [EPC]"
],
"manufacturer_name": [
"Novugen Pharma (USA) LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:82293-034_5e7ce385-737e-736a-e063-6294a90aa87a"